| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | Aug 17, 2022 | Option Exercise | $19.76 | 62,624 | 1,237,269 | 32,596 | Aug 19, 2022, 04:06 PM | |
| CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP OF CORP AFFAIRS & ADMIN. | Aug 18, 2022 | Option Exercise | $22.70 | 2,710 | 61,506 | 2,639 | Aug 19, 2022, 04:06 PM | |
| CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP of Corp Affairs & Admin. | Dec 08, 2021 | Sale | $25.02 | 14,646 | 366,401 | 7,731 | Dec 10, 2021, 04:03 PM | |
| CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP of Corp Affairs & Admin. | Nov 01, 2021 | Sale | $27.46 | 13,279 | 364,657 | 7,731 | Nov 03, 2021, 04:02 PM | |
| CLDX | Celldex Therapeutics, Inc. | Cavanaugh Sarah | SVP of Corp Affairs & Admin. | Jun 10, 2020 | Buy | $4.83 | 1,050 | 5,071 | 1,367 | Jun 11, 2020, 07:54 AM |
Menu